Pathstone Holdings
STIM icon

Pathstone Holdings’s Neuronetics STIM Stock Holding History

Pathstone Holdings’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.5K Sell
14,247
-17,984
-56% -$26.2K ﹤0.01% 2328
2026
Q1 		$46.7K Hold
32,231
– – ﹤0.01% 2186
2025
Q4 		$44.5K Buy
+32,231
New +$67.4K ﹤0.01% 2193

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pathstone Holdings's STIM Position: Q2 2026 in Review

Pathstone Holdings reduced its Neuronetics (STIM) stake by 56% in Q2 2026, selling an estimated $26.2K and leaving 14,247 shares worth $18.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2328.

Pathstone Holdings first reported a position in STIM in Q4 2025 and has held it in 3 quarters since. The position peaked at $46.7K in Q1 2026. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Pathstone Holdings held 14,247 shares of Neuronetics worth $18.5K as of Q2 2026.
  • Pathstone Holdings sold 17,984 Neuronetics shares in Q2 2026, an estimated $26.2K.
  • Neuronetics made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #2328 holding.
  • Pathstone Holdings first reported a position in Neuronetics in Q4 2025 and has held it in 3 quarters since.
  • Pathstone Holdings's Neuronetics position peaked at $46.7K in Q1 2026.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.